Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vinorelbine and carboplatin induction followed by concurrent oral vinorelbine with 60 Gy versus 66 Gy radiotherapy in locally advanced non-small cell lung cancer
2008-008920-34Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Jan 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vinorelbine and carboplatin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by University Hospital Odense. Primary endpoint: Local failure-free survival. Started Jan 2009; status: completed.
02
Drugs
vinorelbinecarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2008-008920-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008920-34.